Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
- Status
- RECRUITING
- Phase
- PHASE2
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer ( EV-309 )
- Status
- RECRUITING
- Phase
- PHASE3
A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung CancerInhibitors or Platinum-Based Agents for Small Cell Lung Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3